아시아 태평양 의료 미용 시장 – 2030년까지의 산업 동향 및 예측

TOC 요청 TOC 요청 분석가에게 문의 분석가에게 문의 지금 구매 지금 구매 구매하기 전에 문의 구매하기 전에 문의 무료 샘플 보고서 무료 샘플 보고서

아시아 태평양 의료 미용 시장 – 2030년까지의 산업 동향 및 예측

  • Medical Devices
  • Published Report
  • Mar 2023
  • Asia-Pacific
  • 350 Pages
  • 테이블 수: 45
  • 그림 수: 34

Apac Medical Aesthetics Market

시장 규모 (USD 10억)

연평균 성장률 :  % Diagram

Diagram 예측 기간
2024 –2030
Diagram 시장 규모(기준 연도)
백만 달러
Diagram 시장 규모(예측 연도)
미국 달러 9,744.43
Diagram 연평균 성장률
%
Diagram주요 시장 플레이어
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

>아시아 태평양 의료 미용 시장, 제품 유형별(미용 레이저 기기, 에너지 기기, 바디 컨투어링 기기, 얼굴 미용 기기, 미용 임플란트, 피부 미용 기기), 응용 분야별(노화 방지 및 주름, 얼굴 및 피부 재생, 가슴 확대, 바디 셰이핑 및 셀룰라이트, 문신 제거, 혈관 ​​병변, 흉터, 색소 병변, 재건, 건선 및 백반증 등), 최종 사용자(화장품 센터, 피부과, 병원, 의료 스파, 뷰티 센터), 유통 채널(직접 입찰 및 소매 판매) - 업계 동향 및 2030년까지의 예측.

아시아 태평양 의료 미용 시장

아시아 태평양 의료 미용 시장 분석 및 규모

아시아 태평양 의료 미용 시장은 ALLERGAN, Bausch Health Companies Inc., Lumenis, Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Cynosure, Cutera, Mentor Worldwide LLC 등과 같은 많은 아시아 태평양 업체로 구성되어 있기 때문에 분산되어 있습니다. 이러한 회사의 존재는 지역 전체에서 의료 미용 제품에 대한 경쟁력 있는 가격을 제공합니다. 지역 및 국제 수준에서 이러한 업체가 존재하기 때문에 공급업체와 제조업체는 모든 예산에서 다양한 사양과 특성을 가진 제품을 제공합니다. 증가하는 기술 발전이 시장 성장을 주도하고 있습니다. 또한 주요 시장 업체의 전략적 이니셔티브가 시장 성장을 주도할 것으로 예상됩니다.

아시아 태평양 의료 미용 시장아시아 태평양 의료 미용 시장

Data Bridge Market Research는 아시아 태평양 의료 미용 시장이 2030년까지 9,744.43백만 달러에 도달할 것으로 예상되며, 예측 기간 동안 CAGR은 13.7%가 될 것으로 분석했습니다. 이 시장 보고서는 또한 가격 분석과 기술 발전에 대한 심층적인 내용을 다룹니다.

보고서 메트릭

세부

예측 기간

2023년부터 2030년까지

기준 연도

2022

역사적 연도

2021 (2015-2020까지 사용자 정의 가능)

양적 단위

매출은 백만, 볼륨은 단위, 가격은 USD

다루는 세그먼트

제품 유형(미용 레이저 기기, 에너지 기기, 바디 컨투어링 기기 , 얼굴 미용 기기, 미용 임플란트, 피부 미용 기기), 응용 분야(노화 방지 및 주름, 얼굴 및 피부 재생, 가슴 확대, 바디 셰이핑 및 셀룰라이트, 문신 제거, 혈관 ​​병변, 시어, 색소 병변, 재건, 건선 및 백반증 및 기타), 최종 사용자(화장품 센터, 피부과 클리닉, 병원, 의료 스파 및 뷰티 센터), 유통 채널(직접 입찰 및 소매 판매)

적용 국가

일본, 인도, 중국, 한국, 호주, 태국, 싱가포르, 말레이시아, 인도네시아, 필리핀, 기타 아시아 태평양 지역

시장 참여자 포함

Allergan, Bausch Health Companies Inc., Lumenis, Shanghai Fosun Pharmaceutical(Group) Co. Ltd., Syneron Medical Ltd, BTL, Cutera, Eclipse, Lutronic, Mentor Worldwide LLC, Merz Pharma, Sciton Inc., Sharplight Technologies Inc., Syneron Medical Ltd., Venus Concept 등

시장 정의

Aesthetic devices are an innovative advancement, providing a solution to patients with the ingenuity of creating beauty. Medical aesthetics devices are a growing market owing to their benefits such as maintaining a youthful appearance, pain-free and non-invasive beauty treatments, maintenance-free skin that remains smooth and hairless without the need for shaving, waxing, or unpleasant hair treatments, improving the cosmetic appearance, and technological advancement in medical aesthetics devices.

Medical aesthetics devices are a cosmetic treatment that improves appearance by treating conditions such as acne, unwanted hair, wrinkles, sunspots, and others. The benefits are improved appearance, better health, immediate and long-lasting results, increased self-esteem, and others.

Asia-Pacific Medical Aesthetics Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:

DRIVERS

Aging Population Asia-Pacific

The sole objective of aesthetic surgery in the aging population is to improve psychological well-being by improving or modifying their body image. The normal body structures are reshaped to accomplish this goal. The aesthetic surgery has successfully improved the quality-of-life-index and reduced depression amongst the elderly population. The growth of the aging population Asia-Pacific has led to the growth of the medical aesthetics market. There has been massive growth in the looks industry in recent years, and the aging population has been one of the drivers in this process. The superficial goal of the perfect body depicted by mass media is a major reason for its growth. People's obsession with looking more youthful leads to various breakthroughs in the aesthetic market.

Technological Advancements

The Asia-Pacific medical aesthetics market is booming because of awareness among prospective customers. The drive to possess the perfect figure and shape humans paces the aesthetics market with innovative technological advancements. The aesthetics market itself has been able to attract a huge number of customers Asia-Pacific. Medical Aesthetics have redefined the definition of perfection. With the increase in technological advancements, there is a reduction in side effects and better quality treatments. This, along with increasing awareness among people, drives the Asia-Pacific medical aesthetics market.

OPPORTUNITY

Imminent Health Revolution

The standard of living in developing countries such as India, Brazil, South Africa, Thailand, and many others has improved in the past decade. People opt for different aesthetic surgeries to maintain themselves, giving them better results without stressful physical efforts. The Asia-Pacific medical aesthetics market remains unexplored in many countries, but the increase in awareness about it amongst emerging countries is leading to its further growth.

RESTRAINT/CHALLENGE

Regulatory scenario

Every medical aesthetics company, no matter how big or small or which market it covers, must adhere to the regulatory requirements. Medical aesthetics is under stringent government regulations. The manufacturers of medical aesthetic devices and products must go through various testing levels before the final validation. Complying with the FDA's standards requires specialized skill sets, resources, time, and money. Medical aesthetics are subjected to pre-market approval application (PMA) per the Federal Food, Drug, and Cosmetic Act (FFDC) and its regulations.

Post-COVID-19 Impact on the Asia-Pacific Medical Aesthetics Market

COVID-19 negatively impacted the Asia-Pacific medical aesthetics market due to the shutdown of Asia-Pacific manufacturing sectors, logistics and transportation, and lack of testing for the product.

The COVID-19 pandemic has impacted the market to an extent negative manner. However, increasing government support and continuous technological advancement are expected to provide lucrative opportunities for market growth. Moreover, increasing partnerships, acquisitions, and collaboration among market players and the growing awareness of medical aesthetics products in the region are expected to fuel the market growth further. Also, the growth has been high since the market opened after COVID-19, and it is expected that there will be considerable growth in the sector. The market players are conducting multiple R&D activities to improve the technology involved in the product. With this, the companies will bring advancement and innovation to the market.

Recent Developments

  • In February 2022, Allergan (a subsidiary of AbbVie Inc.) announced the FDA approval of JUVÉDERM VOLBELLA XC to improve infraorbital hollows in adults above 21. This helped the company to expand the product portfolio of aesthetics in the U.S. market.
  • In January 2022, Mentor Worldwide LLC (a subsidiary of the Johnson & Johnson Medical Devices Companies) announced that the FDA had approved the MENTOR MemoryGel BOOST breast implant for breast augmentation and breast reconstruction. This product has helped the company to expand its product portfolio of aesthetics in the U.S. market.

Asia-Pacific Medical Aesthetics Market Scope

The Asia-Pacific medical aesthetics market is segmented into four notable segments based on product type, application, end user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and insights to help them make strategic decisions for identifying core market applications.

By Product Type

  • Aesthetic Laser Devices
  • Energy Devices
  • Body Contouring Devices
  • Facial Aesthetic Devices
  • Aesthetic Implants
  • Skin Aesthetic Devices

Based on product type, the market is segmented into aesthetic laser devices, energy devices, body contouring devices, facial aesthetic devices, aesthetic implants, and skin aesthetic devices.

By Application

  • 노화방지 및 주름
  • 얼굴 및 피부 재생
  • 가슴 확대
  • 바디 셰이핑과 셀룰라이트
  • 문신 제거
  • 혈관 병변
  • 시어스, 색소 병변 재건
  • 건선과 백반증
  • 기타

시장은 응용 분야별로 노화 방지 및 주름, 얼굴 및 피부 재생, 가슴 확대, 바디 셰이핑 및 셀룰라이트, 문신 제거, 혈관 ​​병변, 흉터, 색소 병변, 재건, 건선 및 백반증 등으로 세분화됩니다.

최종 사용자별

  • 화장품 센터
  • 피부과 병원
  • 병원
  • 의료 스파 및 뷰티 센터

최종 사용자를 기준으로 시장은 화장품 센터, 피부과 병원, 병원, 메디컬 스파, 뷰티 센터로 구분됩니다.

유통 채널별

  • 직접 입찰
  • 소매 판매

유통 채널을 기준으로 시장은 직접 입찰과 소매, 판매로 세분화됩니다.

의료 미용 시장

아시아 태평양 의료 미용 시장 지역 분석/통찰력

위에 언급된 대로, 아시아 태평양 의료 미용 시장을 분석하고, 국가, 제품 유형, 응용 분야, 최종 사용자 및 유통 채널별로 시장 규모에 대한 통찰력과 추세를 제공합니다.

이 시장 보고서에서 다루는 국가는 일본, 인도, 중국, 한국, 호주, 태국, 싱가포르, 말레이시아, 인도네시아, 필리핀, 그리고 아시아 태평양의 나머지 지역입니다.

일본은 가장 큰 시장 점유율로 시장을 지배할 것으로 예상됩니다. 이 점유율은 Allergan, Bausch Health Companies Inc., Lumenis 등과 같은 주요 시장 참여자의 존재에 기인합니다. 주요 시장 참여자의 전략적 이니셔티브와 새로운 기술의 침투는 이 나라의 예측 기간 동안 시장 성장을 촉진할 것으로 예상됩니다.

보고서의 국가 섹션은 또한 현재 및 미래 시장 추세에 영향을 미치는 개별 시장 영향 요인과 시장 규제의 변화를 제공합니다. 하류 및 상류 가치 사슬 분석, 기술 추세, 포터의 5가지 힘 분석, 사례 연구와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 몇 가지 포인터입니다. 또한 아시아 태평양 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세의 영향 및 무역 경로가 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.

경쟁 환경 및 아시아 태평양 의료 미용 시장 점유율 분석

아시아 태평양 의료 미용 시장 경쟁 구도는 경쟁자에 대한 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, R&D 투자, 새로운 시장 이니셔티브, 아시아 태평양 지역 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 프로그램 우세입니다. 제공된 위의 데이터 포인트는 시장과 관련된 회사의 초점에만 관련이 있습니다.

아시아 태평양 의료 미용 시장에서 활동하는 주요 기업으로는 Allergan, Bausch Health Companies Inc., Lumenis, Shanghai Fosun Pharmaceutical(Group)Co. Ltd., Syneron Medical Ltd, BTL, Cutera, Lutronic, Mentor Worldwide LLC 등이 있습니다.


SKU-

세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요

  • 대화형 데이터 분석 대시보드
  • 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
  • 사용자 정의 및 질의를 위한 리서치 분석가 액세스
  • 대화형 대시보드를 통한 경쟁자 분석
  • 최신 뉴스, 업데이트 및 추세 분석
  • 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
데모 요청

목차

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE ASIA PACIFIC MEDICAL AESTHETICS MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRODUCT TYPE LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET APPLICATION COVERAGE GRID

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PORTER’S FIVE FORCES

4.2 PESTEL ANALYSIS

4.3 CUSTOMISED DATA:

4.3.1 INTRODUCTION

5 ASIA PACIFIC MEDICAL AESTHETICS MARKET, REGULATIONS

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 AGING POPULATION ASIA PACIFICLY

6.1.2 TECHNOLOGICAL ADVANCEMENTS

6.1.3 KEY PLAYERS ARE TAKING STRATEGIC DECISIONS TO GAIN MARKET SHARE

6.2 RESTRAINTS

6.2.1 STRINGENT REGULATORY POLICIES

6.2.2 HIGH COST FOR THE TREATMENTS.

6.3 OPPORTUNITIES

6.3.1 IMMENT HEALTH REVOLUTION

6.3.2 GROWING MEDICAL TOURISM IN ASIA

6.4 CHALLENGE

6.4.1 INCREASING COMPETITORS

7 ASIA PACIFIC MEDICAL AESTHETICS MARKET, BY PRODUCT TYPE

7.1 OVERVIEW

7.2 AESTHETIC LASER DEVICES

7.2.1 ABLATIVE SKIN RESURFACING DEVICES

7.2.1.1 CO2 LASER

7.2.1.2 ERBIUM LASER

7.2.1.3 OTHERS

7.2.2 NON-ABLATIVE FRACTIONAL LASER RESURFACING DEVICES

7.2.2.1 RADIOFREQUENCY

7.2.2.2 INTENSE PULSED LIGHT

7.2.2.3 FRACTIONAL LASER

7.2.2.4 THE Q-SWITCHED ND:YAG LASER

7.2.2.5 OTHERS

7.3 ENERGY DEVICES

7.3.1 LASER SURGERY DEVICES

7.3.2 ELECTROCAUTERY DEVICES

7.3.3 ELECTROSURGERY DEVICES

7.3.4 CRYOSURGERY DEVICES

7.3.5 HARMONIC SCALPEL

7.3.6 MICROWAVE DEVICES

7.4 BODY CONTOURING DEVICES

7.4.1 LIPOSUCTION

7.4.2 NONSURGICAL SKIN TIGHTENING

7.4.3 CELLULITE TREATMENT

7.5 FACIAL AESTHETIC DEVICES

7.5.1 BOTOX INJECTION

7.5.2 DERMAL FILLERS

7.5.2.1 NATURAL DERMAL FILLERS

7.5.2.2 SYNTHETIC DERMAL FILLERS

7.5.3 COLLAGEN INJECTIONS

7.5.4 CHEMICAL PEEL

7.5.5 FACIAL TONING

7.5.6 FRAXEL

7.5.7 COSMETIC ACUPUNCTURE

7.5.8 ELECTROTHERAPY

7.5.9 MICRODERMABRASION

7.5.10 PERMANENT MAKEUP

7.6 AESTHETIC IMPLANTS

7.6.1 BREAST AUGMENTATION

7.6.1.1 SALINE IMPLANTS

7.6.1.2 SILICON IMPLANTS

7.6.2 BUTTOCK AUGMENTATION

7.6.3 AESTHETIC DENTAL IMPLANTS

7.6.3.1 DENTAL TITANIUM IMPLANTS

7.6.3.2 DENTAL ZERCONIUM IMPLANTS

7.6.4 FACIAL IMPLANTS

7.6.5 SOFT TISSUE IMPLANTS

7.6.6 TRANSDERMAL IMPLANT

7.6.7 OTHERS

7.7 SKIN AESTHETIC DEVICES

7.7.1 LASER SKIN RESURFACING DEVICES

7.7.2 NON SURGICAL SKIN TIGHTENING DEVICES

7.7.3 LIGHT THERAPY DEVICES

7.7.4 TATTOO REMOVAL DEVICES

7.7.5 MICRO-NEEDLING PRODUCTS

7.7.6 THREAD LIFT PRODUCTS

7.7.7 NAIL TREATMENT LASER DEVICES

7.7.8 OTHERS

8 ASIA PACIFIC MEDICAL AESTHETICS MARKET, BY APPLICATION

8.1 OVERVIEW

8.2 ANTI-AGING AND WRINKLES

8.3 FACIAL AND SKIN REJUVENATION

8.4 BREAST ENHANCEMENT

8.5 BODY SHAPING AND CELLULITE

8.6 TATTOO REMOVAL

8.7 VASCULAR LESIONS

8.7.1 SEARS, PIGMENT LESIONS, RECONSTRUCTIVE

8.8 PSORIASIS AND VITILIGO

8.9 OTHERS

9 ASIA PACIFIC MEDICAL AESTHETICS MARKET, BY END USER

9.1 OVERVIEW

9.2 COSMETIC CENTERS

9.3 DERMATOLOGY CLINICS

9.4 HOSPITALS

9.5 MEDICAL SPAS AND BEAUTY CENTERS

10 ASIA PACIFIC MEDICAL AESTHETICS MARKET, BY DISTRIBUTION CHANNEL

10.1 OVERVIEW

10.2 DIRECT TENDER

10.3 RETAIL

11 ASIA PACIFIC MEDICAL AESTHETIC DEVICES MARKET, BY REGION

11.1 ASIA PACIFIC

11.1.1 CHINA

11.1.2 INDIA

11.1.3 JAPAN

11.1.4 SOUTH KOREA

11.1.5 SINGAPORE

11.1.6 THAILAND

11.1.7 MALAYSIA

11.1.8 INDONESIA

11.1.9 AUSTRALIA

11.1.10 PHILIPPINES

11.1.11 REST OF ASIA-PACIFIC

12 ASIA PACIFIC MEDICAL AESTHETICS MARKET: COMPANY LANDSCAPE

12.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC

13 COMPANY PROFILE

13.1 ALLERGAN

13.1.1 COMPANY SNAPSHOT

13.1.2 SWOT ANALYSIS

13.1.3 REVENUE ANALYSIS

13.1.4 COMPANY SHARE ANALYSIS

13.1.5 PRODUCT PORTFOLIO

13.1.6 RECENT DEVELOPMENTS

13.1.7 DATA BRIDGE MARKET RESEARCH ANALYSIS

13.2 BAUSCH HEALTH COMPANIES INC.

13.2.1 COMPANY SNAPSHOT

13.2.2 SWOT ANALYSIS

13.2.3 REVENUE ANALYSIS

13.2.4 PRODUCT PORTFOLIO

13.2.5 RECENT DEVELOPMENTS

13.2.6 DATA BRIDGE MARKET RESEARCH ANALYSIS

13.3 LUMENIS

13.3.1 COMPANY SNAPSHOT

13.3.2 SWOT ANALYSIS

13.3.3 COMPANY SHARE ANALYSIS

13.3.4 PRODUCT PORTFOLIO

13.3.5 RECENT DEVELOPMENTS

13.3.6 DATA BRIDGE MARKET RESEARCH ANALYSIS

13.4 SHANGHAI FOSUN PHARMACEUTICAL(GROUP)CO., LTD.

13.4.1 COMPANY SNAPSHOT

13.4.2 SWOT ANALYSIS

13.4.3 REVENUE ANALYSIS

13.4.4 PRODUCT PORTFOLIO

13.4.5 RECENT DEVELOPMENTS

13.4.6 DATA BRIDGE MARKET RESEARCH ANALYSIS

13.5 CYNOSURE

13.5.1 COMPANY SNAPSHOT

13.5.2 SWOT ANALYSIS

13.5.3 COMPANY SHARE ANALYSIS

13.5.4 PRODUCT PORTFOLIO

13.5.5 RECENT DEVELOPMENTS

13.5.6 DATA BRIDGE MARKET RESEARCH ANALYSIS

13.6 AEROLASE CORP.

13.6.1 COMPANY SNAPSHOT

13.6.2 PRODUCT PORTFOLIO

13.6.3 RECENT DEVELOPMENTS

13.7 A.R.C. LASER GMBH

13.7.1 COMPANY SNAPSHOT

13.7.2 PRODUCT PORTFOLIO

13.7.3 RECENT DEVELOPMENT

13.8 ASCLEPION LASER TECHNOLOGIES GMBH

13.8.1 COMPANY SNAPSHOT

13.8.2 PRODUCT PORTFOLIO

13.8.3 RECENT DEVELOPMENT

13.9 BTL

13.9.1 COMPANY SNAPSHOT

13.9.2 PRODUCT PORTFOLIO

13.9.3 RECENT DEVELOPMENTS

13.1 CUTERA

13.10.1 COMPANY SNAPSHOT

13.10.2 REVENUE ANALYSIS

13.10.3 COMPANY SHARE ANALYSIS

13.10.4 PRODUCT PORTFOLIO

13.10.5 RECENT DEVELOPMENTS

13.11 ECLIPSE

13.11.1 COMPANY SNAPSHOT

13.11.2 PRODUCT PORTFOLIO

13.11.3 RECENT DEVELOPMENTS

13.12 LUTRONIC

13.12.1 COMPANY SNAPSHOT

13.12.2 PRODUCT PORTFOLIO

13.12.3 RECENT DEVELOPMENTS

13.13 MENTOR WORLDWIDE LLC

13.13.1 COMPANY SNAPSHOT

13.13.2 REVENUE ANALYSIS

13.13.3 COMPANY SHARE ANALYSIS

13.13.4 PRODUCT PORTFOLIO

13.13.5 RECENT DEVELOPMENT

13.14 MERZ PHARMA

13.14.1 COMPANY SNAPSHOT

13.14.2 PRODUCT PORTFOLIO

13.14.3 RECENT DEVELOPMENTS

13.15 QUANTA SYSTEM

13.15.1 COMPANY SNAPSHOT

13.15.2 PRODUCT PORTFOLIO

13.15.3 RECENT DEVELOPMENTS

13.16 SCITON INC.

13.16.1 COMPANY SNAPSHOT

13.16.2 PRODUCT PORTFOLIO

13.16.3 RECENT DEVELOPMENTS

13.17 SHARPLIGHT TECHNOLOGIES INC

13.17.1 COMPANY SNAPSHOT

13.17.2 PRODUCT PORTFOLIO

13.17.3 RECENT DEVELOPMENT

13.18 SYNERON MEDICAL LTD.

13.18.1 COMPANY SNAPSHOT

13.18.2 PRODUCT PORTFOLIO

13.18.3 RECENT DEVELOPMENTS

13.19 VENUS CONCEPT

13.19.1 COMPANY SNAPSHOT

13.19.2 PRODUCT PORTFOLIO

13.19.3 RECENT DEVELOPMENTS

14 QUESTIONNAIRE

15 RELATED REPORTS

표 목록

TABLE 1 NUMBER OF WORLDWIDE SURGICAL PROCEDURES PERFORMED BY PLASTIC SURGEONS IN 2020

TABLE 2 NUMBER OF WORLDWIDE NON-SURGICAL PROCEDURES PERFORMED BY PLASTIC SURGEONS IN 2020

TABLE 3 IN 2020, THE TOTAL NUMBER OF SURGICAL PROCEDURES IN RUSSIA WAS 478,200.

TABLE 4 IN 2020, THE TOTAL NUMBER OF NON-SURGICAL PROCEDURES IN RUSSIA WAS 143,400.

TABLE 5 REGULATORY AUTHORITIES FOR MEDICAL AESTHETICS

TABLE 6 COST OF TREATMENT IN VARIOUS COUNTRIES

TABLE 7 THE FOLLOWING TABLE SHOWS THE TOTAL NUMBER OF PLASTIC SURGERIES OCCURRED IN DIFFERENT COUNTRIES:

TABLE 8 THE BELOW TABLE SHOWS THE AVERAGE SAVINGS ON THE TREATMENT AS COMPARED TO U.S.

TABLE 9 TABLE OF COST COMPARISON OF THE TREATMENT IN U.S. AND SHANGHAI

TABLE 10 ASIA PACIFIC MEDICAL AESTHETICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 11 ASIA PACIFIC AESTHETIC LASER DEVICES IN MEDICAL AESTHETIC MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 12 ASIA PACIFIC AESTHETIC LASER DEVICES IN MEDICAL AESTHETIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 13 ASIA PACIFIC ABLATIVE RESURFACING DEVICES IN AESTHETIC LASER MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 14 ASIA PACIFIC NON-ABLATIVE RESURFACING DEVICES IN AESTHETIC LASER MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 15 ASIA PACIFIC ENERGY DEVICES IN MEDICAL AESTHETIC MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 16 ASIA PACIFIC ENERGY DEVICES IN MEDICAL AESTHETIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 17 ASIA PACIFIC BODY CONTOURING DEVICES IN MEDICAL AESTHETICS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 18 ASIA PACIFIC BODY CONTOURING DEVICES IN MEDICAL AESTHETICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 19 ASIA PACIFIC FACIAL AESTHETIC DEVICES IN MEDICAL AESTHETICS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 20 ASIA PACIFIC FACIAL AESTHETIC DEVICES IN MEDICAL AESTHETICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 21 ASIA PACIFIC DERMAL FILLERS IN MEDICAL AESTHETICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 22 ASIA PACIFIC AESTHETIC IMPLANTS IN MEDICAL AESTHETICS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 23 ASIA PACIFIC AESTHETIC IMPLANTS IN MEDICAL AESTHETICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 24 ASIA PACIFIC BREAST AUGMENTATION IN MEDICAL AESTHETICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 25 ASIA PACIFIC AESTHETIC DENTAL IMPLANTS IN MEDICAL AESTHETICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 26 ASIA PACIFIC SKIN AESTHETIC DEVICES IN MEDICAL AESTHETICS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 27 ASIA PACIFIC SKIN AESTHETIC DEVICES IN MEDICAL AESTHETICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 28 ASIA PACIFIC MEDICAL AESTHETICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 29 ASIA PACIFIC ANTI-AGING AND WRINKLES IN MEDICAL AESTHETICS MARKET, BY REGION , 2021-2030 (USD MILLION)

TABLE 30 ASIA PACIFIC FACIAL AND SKIN REJUVENATION IN MEDICAL AESTHETICS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 31 ASIA PACIFIC BREAST ENHANCEMENT IN MEDICAL AESTHETICS MARKET, BY REGION , 2021-2030 (USD MILLION)

TABLE 32 ASIA PACIFIC BODY SHAPING AND CELLULITE IN MEDICAL AESTHETICS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 33 ASIA PACIFIC TATTOO REMOVAL IN MEDICAL AESTHETICS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 34 ASIA PACIFIC VASCULAR LESIONS IN MEDICAL AESTHETICS MARKET, BY REGION , 2021-2030 (USD MILLION)

TABLE 35 ASIA PACIFIC SEARS, PIGMENT LESIONS, RECONSTRUCTIVE IN MEDICAL AESTHETICS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 36 ASIA PACIFIC PSORIASIS AND VITILIGO IN MEDICAL AESTHETICS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 37 ASIA PACIFIC OTHERS IN MEDICAL AESTHETICS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 38 ASIA PACIFIC MEDICAL AESTHETICS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 39 COSMETIC CENTERS IN MEDICAL AESTHETICS MARKET, BY REGION , 2021-2030 (USD MILLION)

TABLE 40 ASIA PACIFIC DERMATOLOGY CLINICS IN MEDICAL AESTHETICS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 41 ASIA PACIFIC HOSPITALS IN MEDICAL AESTHETICS MARKET, BY REGION , 2021-2030 (USD MILLION)

TABLE 42 ASIA PACIFIC MEDICAL SPAS AND BEAUTY CENTERS IN MEDICAL AESTHETICS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 43 ASIA PACIFIC MEDICAL AESTHETICS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 44 ASIA PACIFIC DIRECT TENDER IN MEDICAL AESTHETICS MARKET, BY REGION , 2021-2030 (USD MILLION)

TABLE 45 ASIA PACIFIC RETAIL IN MEDICAL AESTHETICS MARKET, BY REGION, 2021-2030 (USD MILLION)

그림 목록

FIGURE 1 ASIA PACIFIC MEDICAL AESTHETICS MARKET: SEGMENTATION

FIGURE 2 ASIA PACIFIC MEDICAL AESTHETICS MARKET: DATA TRIANGULATION

FIGURE 3 ASIA PACIFIC MEDICAL AESTHETICS MARKET: DROC ANALYSIS

FIGURE 4 ASIA PACIFIC MEDICAL AESTHETICS MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS

FIGURE 5 ASIA PACIFIC MEDICAL AESTHETICS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 ASIA PACIFIC MEDICAL AESTHETICS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 ASIA PACIFIC MEDICAL AESTHETICS MARKET: DBMR MARKET POSITION GRID

FIGURE 8 ASIA PACIFIC MEDICAL AESTHETICS MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 9 ASIA PACIFIC MEDICAL AESTHETICS MARKET: SEGMENTATION

FIGURE 10 THE INCREASE IN THE AGING POPULATION ASIA PACIFICLY IS EXPECTED TO DRIVE THE ASIA PACIFIC MEDICAL AESTHETICS MARKET GROWTH IN THE FORECAST PERIOD

FIGURE 11 THE AESTHETIC LASER DEVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC MEDICAL AESTHETICS MARKET IN 2023 & 2030

FIGURE 12 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA PACIFIC MEDICAL AESTHETICS MARKET

FIGURE 13 ASIA PACIFIC MEDICAL AESTHETICS MARKET: BY PRODUCT TYPE, 2022

FIGURE 14 ASIA PACIFIC MEDICAL AESTHETICS MARKET : BY PRODUCT TYPE, 2023-2030 (USD MILLION)

FIGURE 15 ASIA PACIFIC MEDICAL AESTHETICS MARKET : BY PRODUCT TYPE, CAGR (2023-2030)

FIGURE 16 ASIA PACIFIC MEDICAL AESTHETICS MARKET : BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 17 ASIA PACIFIC MEDICAL AESTHETICS MARKET: BY APPLICATION, 2022

FIGURE 18 ASIA PACIFIC MEDICAL AESTHETICS MARKET: BY APPLICATION, 2023-2030 (USD MILLION)

FIGURE 19 ASIA PACIFIC MEDICAL AESTHETICS MARKET: BY APPLICATION, CAGR (2023-2030)

FIGURE 20 ASIA PACIFIC MEDICAL AESTHETICS MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 21 ASIA PACIFIC MEDICAL AESTHETICS MARKET: BY END USER, 2022

FIGURE 22 ASIA PACIFIC MEDICAL AESTHETICS MARKET: BY END USER, 2023-2030 (USD MILLION)

FIGURE 23 ASIA PACIFIC MEDICAL AESTHETICS MARKET: BY END USER, CAGR (2023-2030)

FIGURE 24 ASIA PACIFIC MEDICAL AESTHETICS MARKET: BY END USER, LIFELINE CURVE

FIGURE 25 ASIA PACIFIC MEDICAL AESTHETICS MARKET: BY DISTRIBUTION CHANNEL, 2022

FIGURE 26 ASIA PACIFIC MEDICAL AESTHETICS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)

FIGURE 27 ASIA PACIFIC MEDICAL AESTHETICS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)

FIGURE 28 ASIA PACIFIC MEDICAL AESTHETICS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 29 ASIA-PACIFIC MEDICAL AESTHETICS MARKET: SNAPSHOT (2022)

FIGURE 30 ASIA-PACIFIC MEDICAL AESTHETICS MARKET: BY COUNTRY (2022)

FIGURE 31 ASIA-PACIFIC MEDICAL AESTHETICS MARKET: BY COUNTRY (2023 & 2030)

FIGURE 32 ASIA-PACIFIC MEDICAL AESTHETICS MARKET: BY COUNTRY (2023 & 2030)

FIGURE 33 ASIA-PACIFIC MEDICAL AESTHETICS MARKET: BY TEST TYPE (2023-2030)

FIGURE 34 ASIA PACIFIC MEDICAL AESTHETICS MARKET: COMPANY SHARE 2022 (%)

자세한 정보 보기 Right Arrow

연구 방법론

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.

DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.

사용자 정의 가능

Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.

자주 묻는 질문

Major companies in the Asia-Pacific Medical Aesthetics Market are Allergan, Bausch Health Companies Inc., Lumenis, Shanghai Fosun Pharmaceutical(Group)Co. Ltd., Syneron Medical Ltd, BTL, Cutera, Eclipse, Lutronic, Mentor Worldwide LLC, Merz Pharma, Sciton Inc., Sharplight Technologies Inc, Syneron Medical Ltd., Venus Concept.
The Asia-Pacific Medical Aesthetics Market growth rate is 13.7% during the forecast period.
Aging Population Asia-Pacific & Technological Advancements are the growth drivers of the Asia-Pacific Medical Aesthetics Market.
The product type, application, end user, and distribution channel are the factors on which the Asia-Pacific Medical Aesthetics Market research is based.
The Asia-Pacific Medical Aesthetics Market will be worth USD 9,744.43 million in the forecast period by 2030.